1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Relugolix + Enzalutamide Study in High-Risk Prostate CancerDisease Attributes, Disease Progression, Neoplasm, Residual, Neoplastic Processes, Pathologic Complete Response, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasmRecruitingPhase 12026-03-05NCT06130995